It highlights potential avenues for future research into the pathophysiology of RPE65-associated LCA/EOSRD and emphasizes the necessity for extensive genetic studies within the Japanese population to elucidate the spectrum of RPE65 variants and their clinical presentations. The gene discussed is RPE65; the disease is severe early-childhood-onset retinal dystrophy.